Find expertise

1 - 10 of 2707 results

Search term:

Pediatric Oncology KU Leuven

Responsible

Pediatric Oncology is a research group within Oncology that focuses on younger patients. The Department of Oncology promotes synergy in innovative oncological research. By creating a close link between bed and couch and by taking advantage of advanced technologies, our researchers want to expose important molecular mechanisms behind the development and progression of cancer and maximize the chances of translating these findings into better ...

Department of Oncology KU Leuven

Responsible

The Department of Oncology at the KU Leuven fosters synergy in innovative oncological research. By creating a close link between bed and bench and by capitalizing on advanced technologies, our researchers aim to unravel key molecular mechanisms underlying the development and progression of cancer and to maximize opportunities to translate these findings into better clinical biomarkers, adaptive strategies and innovative treatments

Head and Neck Oncology KU Leuven

The research group Head and Neck Oncologyfocuses on outcomes research and surgical innovation and technology assessment for promoting minimally invasive surgical approaches.

On the outcomes research part, (1) our team has recently developed and validated a clinicopathologic prognostic index. We are exploring the possibilities of evaluating molecular biological factors for inclusion in the index and optimizing prognostic accuracy. (2) ...

Clinical Digestive Oncology KU Leuven

The research group Clinical Digestive Oncology focuses on:

  1. Clinical research on new treatment modalities with a focus on strategy of treatment sequences and on new drugs, including also radionucleide treatment. The clinical research is also focused towards the multidisciplinary management and multimodal treatment of gastrointestinal tumors.
  2. Clinical research on optimization of diagnostic modalities including response ...

Laboratory of Experimental Oncology KU Leuven

There are five main research topics in the Laboratory of Experimental Oncology ( LEO):

  • molecular characterization of rare tumors focused on identification of predictive biomarkers;
  • preclinical efficacy studies of novel targeted agents in soft tissue sarcomas using a unique panel of xenograft models derived from patient samples;
  • translational research, identifying prognostic markers related to experimental treatment, ...

Molecular Digestive Oncology KU Leuven

Responsible

The laboratory for Molecular Digestive Oncology focusses on gastro-intestinal cancers and currently has two types of activities:

  • large molecular annotation projects, aimed at better describing the overall molecular identity of GI tumors and potential subtypes. Activities here include in depth molecular annotation of tumor series, state of the art bioinformatics for subtype derivation and biological annotation, comparisons of ...

Molecular Imaging, Pathology, Radiotherapy & Oncology (MIPRO) University of Antwerp

The department of Oncology houses research topics in - Oncology (most recent projects: Validation of Urokinase plasminogen activator (uPA) as a therapeutic target and biomarker; Molecular characterization of circulating tumour cells in patients with breast cancer.) - Pathological anatomy - Nuclear medicine - Radiotherapy.

Laboratory for Medical and Molecular Oncology Vrije Universiteit Brussel

Responsible

As part of the Oncology Research Center, the Laboratory for Medical & Molecular Oncology (LMMO) at the VUB Faculty of Medicine engages in several major research initiatives: to study pancreatic cancer biology (Prof. Dr. Ilse Rooman), to study cancer immunotherapy including autologous dendritic cell therapies (Prof. Dr. Bart Neyns) and to advance targeted therapies for cancer in genomically defined patients (personalized medicine, ...

Surgical Oncology KU Leuven

Responsible

There are four main topics of research which are closely related to major areas of clinical work. 1. Identifying prognostic and predictive biomarkers in breast cancer patients. 2. Molecular annotation of somatic mutations in sarcoma and the discovery and validation of genetic biomarkers and establishing cell lines and tumor xenografts. 3. Genetic polymorphism in melanoma; vitamin D and malignant melanoma; characterization of tumor response to ...